Showing 1 - 20 results of 748 for search '"вирус папилломы человека"', query time: 0.78s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
    Academic Journal

    Source: Biomedical Photonics; Том 14, № 2 (2025); 31-39 ; 2413-9432

    File Description: application/pdf

    Relation: https://www.pdt-journal.com/jour/article/view/720/488; McLaughlin-Drubin M. E., Munger K. Viruses associated with human cancer // Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. – 2008. – Vol. 1782. – P. 127-150.; Plummer M., de Martel C., Vignat J., Ferlay J., Bray F., Franceschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis // The Lancet Global Health. – 2016. – Vol. 9. – P. e609-e616.; Kotsopoulos J., Lubinski J., Gronwald J. Updates to the National Cancer Institute’s PDQ Information from Recently Published Oncology Research. – 2017. – Vol. 9. – P. 303.; Asiaf A., Ahmad S. T., Mohammad S. O., Zargar M. A. Review of the current knowledge on the epidemiology, pathogenesis, and prevention of human papillomavirus infection // European Journal of Cancer Prevention. – 2014. – Vol. 3. – P. 206-224.; McCredie M. R., Sharples K. J., Paul C., Baranyai J., Medley G., Jones R. W., Skegg D. C. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study // The lancet oncology. – 2008. – Vol. 5. – P. 425-434.; Munk A. C., Gudlaugsson E., Ovestad I. T., Lovslett K., Fiane B., van Diermen Hidle B., Kruse A.-J., Skaland I., Janssen E. A., Baak J. P. Interaction of epithelial biomarkers, local immune response and condom use in cervical intraepithelial neoplasia 2–3 regression // Gynecologic oncology. – 2012. – Vol. 3. ¬– P. 489-494.; Segura S. E., Ramos-Rivera G., Hakima L., Suhrland M., Khader S. Low- grade squamous intraepithelial lesion, cannot rule out high-grade lesion: Diagnosis, histological outcomes and human papillomavirus results // Cytopathology. – 2019. – Vol. 1. – P. 99-104.; Ferlay J., Colombet M., Soerjomataram I., Siegel R., Torre L., Jemal A. Global and regional estimates of the incidence and mortality for 38 cancers: GLOBOCAN 2018. Lyon: International Agency for Research on Cancer // World Health Organization. – 2018. – Vol. 394. – P. 424.; Nene B. M., Hiremath P. S., Kane S., Fayette J.-M., Shastri S. S., Sankaranarayanan R. Effectiveness, safety, and acceptability of cryotherapy by midwives for cervical intraepithelial neoplasia in Maharashtra, India // International Journal of Gynecology & Obstetrics. – 2008. – Vol. 3. – P. 232-236.; Rema P., Suchetha S., Thara S., Fayette J. M., Wesley R., Sankaranarayanan R. Effectiveness and safety of loop electrosurgical excision procedure in a low-resource setting // International Journal of Gynecology & Obstetrics. – 2008. – Vol. 2. – P. 105-110.; Shanazarov N. A., Zinchenko S. V., Kisikova S. D., Rizvanov A. A., Smailova S., Petukhov K. A., Salmaganbetova Z. Z. Photodynamic Therapy In The Treatment Of Hpv-Associated Cervical Cancer: Mechanisms, Challenges And Future Prospects // Biomedical Photonics. – 2024. – Vol. 13. ¬– P. 47-55.; Tzerkovsky D. A., Dunaevskaya V. V. Laser technologies in treatment of cervical intraepytelial neoplasia (review) // Biomedical Photonics. – 2020. – Vol 3. – P. 30-39.; Szpringer E., Lutnicki K., Marciniak A. Photodynamic therapy-- mechanism and employment // Annales Universitatis Mariae Curie- Sklodowska. Sectio D: Medicina. – 2004. – Vol. 59. – P. 498-502.; Trushina O. I., Filonenko E. V., Novikova E. G., Mukhtarulina S. V. Photodynamic therapy in the prevention of hpv-induced recurrences of precancer and initial cancer of the cervix // Biomedical Photonics. – 2024. – Vol. 13. – P. 42-46.; Dobson J., de Queiroz G. F., Golding J. P. Photodynamic therapy and diagnosis: Principles and comparative aspects // The Veterinary Journal. – 2018. – Vol. 233. – P. 8-18.; Kou J., Dou D., Yang L. Porphyrin photosensitizers in photodynamic therapy and its applications // Oncotarget. – 2017. – Vol 46. – P. 81591.; Stylli S. S., Howes M., MacGregor L., Rajendra P., Kaye A. H. Photodynamic therapy of brain tumours: evaluation of porphyrin uptake versus clinical outcome // Journal of Clinical Neuroscience. – 2004. – Vol. 6. – P. 584-596.; Yoshida T., Saeki T., Ohashi S., Okudaira T., Lee M., Yoshida H., Maruoka H., Ito H., Funasaka S., Kato H. Clinical study of photodynamic therapy for laryngeal cancer // Nippon Jibiinkoka Gakkai Kaiho. – 1995. – Vol. 5. – P. 795-804,927.; Koizumi N., Harada Y., Minamikawa T., Tanaka H., Otsuji E., Takamatsu T. Recent advances in photodynamic diagnosis of gastric cancer using 5-aminolevulinic acid // World Journal of Gastroenterology. – 2016. – Vol. 3. – P. 1289.; Harada Y., Murayama Y., Takamatsu T., Otsuji E., Tanaka H. 5-aminolevulinic acid-induced protoporphyrin IX fluorescence imaging for tumor detection: Recent advances and challenges // International journal of molecular sciences. – 2022. – Vol. 12. – P. 6478.; Zavedeeva V. E., Efendiev K. T., Kustov D. M., Loschenova L. Y., Loschenov V. B. Dual-Wavelength Fluorescence Study Of In Vivo Accumulation And Formation Of 5-Ala-Induced Porphyrins // Biomedical Photonics. – 2025. – Vol. 1. – P. 36-46.; Ivanova-Radkevich V. I., Kuznetsova O. M., Filonenko E. V. The Role Of Membrane Transport Proteins In 5-Alk-Induced Accumulation Of Protoporphyrin Ix In Tumor Cells // Biomedical Photonics. – 2024. – Vol. 2. – P. 43-48.; Akbarzadeh A., Rezaei-Sadabady R., Davaran S., Joo S. W., Zarghami N., Hanifehpour Y., Samiei M., Kouhi M., Nejati-Koshki K. Liposome: classification, preparation, and applications // Nanoscale Research Letters. – 2013. – Vol. 1. – P. 102.; Rkein A. M., Ozog D. M. Photodynamic Therapy // Dermatologic Clinics. – 2014. – Vol. 3. – P. 415-425.; Hillemanns P., Soergel P., Löning M. Fluorescence diagnosis and photodynamic therapy for lower genital tract diseases – A review // Medical Laser Application. – 2009. – Vol. 24. – P. 10-17.; Hillemanns P., Weingandt H., Baumgartner R., Diebold J., Xiang W., Stepp H. Photodetection of cervical intraepithelial neoplasia using 5-aminolevulinic acid–induced porphyrin fluorescence // Cancer. – 2000. – Vol. 10. – P. 2275-2282.; Chen Y., Xu Y., Zhang Z., Xiong Z., Wu D. 5-aminolevulinic acid- mediated photodynamic therapy effectively ameliorates HPV- infected cervical intraepithelial neoplasia // American Journal of Translational Research. – 2022. – Vol. 4. – P. 2443.; Poreba E., Broniarczyk J. K., Gozdzicka-Jozefiak A. Epigenetic mechanisms in virus-induced tumorigenesis // Clinical epigenetics. – 2011. – Vol. 2. – P. 233-247.; Fu Y., Bao Y., Hui Y., Gao X., Yang M., Chang J. Topical photodynamic therapy with 5-aminolevulinic acid for cervical high-risk HPV infection // Photodiagnosis and photodynamic therapy. – 2016. – Vol. 13. – P. 29-33.; Bodner K., Bodner-Adler B., Wierrani F., Kubin A., Szölts-Szölts J., Spängler B., Grünberger W. Cold-knife conization versus photodynamic therapy with topical 5-aminolevulinic acid (5- ALA) in cervical intraepithelial neoplasia (CIN) II with associated human papillomavirus infection: a comparison of preliminary results // Anticancer Res. – 2003. – Vol. 2c. – P. 1785-8.; Keefe K. A., Tadir Y., Tromberg B., Berns M., Osann K., Hashad R., Monk B. J. Photodynamic therapy of high-grade cervical intraepithelial neoplasia with 5-aminolevulinic acid // Lasers Surg Med. – 2002. – Vol. 4. – P. 289-93.; Barnett A. A., Haller J. C., Cairnduff F., Lane G., Brown S. B., Roberts D. J. H. A randomised, double-blind, placebo-controlled trial of photodynamic therapy using 5-aminolaevulinic acid for the treatment of cervical intraepithelial neoplasia // International Journal of Cancer. – 2003. – Vol. 6. – P. 829-832.; Inoue K. 5-Aminolevulinic acid-mediated photodynamic therapy for bladder cancer // International Journal of Urology. – 2017. – Vol. 2. – P. 97-101.; Choi M. C., Jung S. G., Park H., Lee S. Y., Lee C., Hwang Y. Y., Kim S. J. Photodynamic therapy for management of cervical intraepithelial neoplasia II and III in young patients and obstetric outcomes // Lasers in Surgery and Medicine. – 2013. – Vol. 9. – P. 564-572.; Bellnier D. A., Greco W. R., Loewen G. M., Nava H., Oseroff A. R., Pandey R. K., Tsuchida T., Dougherty T. J. Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients // Cancer research. – 2003. – Vol. 8. – P. 1806-1813.; Istomin Y. P., Lapzevich T. P., Chalau V. N., Shliakhtsin S. V., Trukhachova T. V. Photodynamic therapy of cervical intraepithelial neoplasia grades II and III with Photolon® // Photodiagnosis and Photodynamic Therapy. – 2010. – Vol. 3. – P. 144-151.; Gu L., Cheng M., Hong Z., Di W., Qiu L. The effect of local photodynamic therapy with 5-aminolevulinic acid for the treatment of cervical low-grade squamous intraepithelial lesions with high-risk HPV infection: A retrospective study // Photodiagnosis and Photodynamic Therapy. – 2021. – Vol. 33. – P. 102172.; Li D., Zhang F., Shi L., Lin L., Cai Q., Xu Y. Treatment of HPV Infection- Associated Low Grade Cervical Intraepithelial Neoplasia with 5-Aminolevulinic Acid-Mediated Photodynamic Therapy // Photodiagnosis and Photodynamic Therapy. – 2020. – Vol. 32. – P. 101974.; Quint K. D., de Koning M. N. C., Quint W. G. V., Pirog E. C. Progression of cervical low grade squamous intraepithelial lesions: in search of prognostic biomarkers // European Journal of Obstetrics & Gynecology and Reproductive Biology. – 2013. – Vol. 2. – P. 501-506.; Ma L., Gao X., Geng L., You K., Wu Z., Li Y., Han Q., Wang Y., Guo H. Efficacy and safety of photodynamic therapy mediated by 5-aminolevulinic acid for the treatment of cervical intraepithelial neoplasia 2: a single-center, prospective, cohort study // Photodiagnosis and photodynamic therapy. – 2021. – Vol. 36. – P. 102472.; Inada N. M., Buzzá H. H., Leite M. F. M., Kurachi C., Trujillo J. R., de Castro C. A., Carbinatto F. M., Lombardi W., Bagnato V. S. Long term effectiveness of photodynamic therapy for CIN treatment // Pharmaceuticals. – 2019. – Vol. 3. – P. 107.; Mizuno M., Mitsui H., Kajiyama H., Teshigawara T., Inoue K., Takahashi K., Ishii T., Ishizuka M., Nakajima M., Kikkawa F. Efficacy of 5-aminolevulinic acid and LED photodynamic therapy in cervical intraepithelial neoplasia: A clinical trial // Photodiagnosis and photodynamic therapy. – 2020. – Vol. 32. – P. 102004.; Keefe K. A., Tadir Y., Tromberg B., Berns M., Osann K., Hashad R., Monk B. J. Photodynamic therapy of high-grade cervical intraepithelial neoplasia with 5-aminolevulinic acid // Lasers in Surgery and Medicine: The Official Journal of the American Society for Laser Medicine and Surgery. – 2002. – Vol. 4. – P. 289-293.; Soergel P., Wang X., Stepp H., Hertel H., Hillemanns P. Photodynamic therapy of cervical intraepithelial neoplasia with hexaminolevulinate // Lasers in Surgery and Medicine: The Official Journal of the American Society for Laser Medicine and Surgery. – 2008. – Vol. 9. – P. 611-615.; Hwang L. Y., Ma Y., Shiboski S. C., Farhat S., Jonte J., Moscicki A.- B. Active Squamous Metaplasia of the Cervical Epithelium Is Associated With Subsequent Acquisition of Human Papillomavirus 16 Infection Among Healthy Young Women // The Journal of Infectious Diseases. – 2012. – Vol. 4. – P. 504-511.; Arbyn M., Redman C. W. E., Verdoodt F., Kyrgiou M., Tzafetas M., Ghaem-Maghami S., Petry K.-U., Leeson S., Bergeron C., Nieminen P., Gondry J., Reich O., Moss E. L. Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis // The Lancet Oncology. – 2017. – Vol. 12. – P. 1665-1679.; Sen P., Ganguly P., Ganguly N. Modulation of DNA methylation by human papillomavirus E6 and E7 oncoproteins in cervical cancer // Oncology letters. – 2018. – Vol. 15. – P. 11-22.; Jacquin E., Baraquin A., Ramanah R., Carcopino X., Morel A., Valmary- Degano S., Bravo I. G., De Sanjosé S., Riethmuller D., Mougin C. Methylation of human papillomavirus type 16 CpG sites at E2-binding site 1 (E2BS1), E2BS2, and the Sp1-binding site in cervical cancer samples as determined by high-resolution melting analysis–PCR // Journal of clinical microbiology. – 2013. – Vol. 10. – P. 3207-3215.; Chang C.-L., Ho S.-C., Su Y.-F., Juan Y.-C., Huang C.-Y., Chao A.-S., Hsu Z.-S., Chang C.-F., Fwu C.-W., Chang T.-C. DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: real-world evidence in Taiwan // Gynecologic oncology. – 2021. – Vol. 2. – P. 429-435.; Kim M.-K., Lee I.-H., Lee K.-H., Lee Y. K., So K. A., Hong S. R., Hwang C.-S., Kee M.-K., Rhee J. E., Kang C. DNA methylation in human papillomavirus-infected cervical cells is elevated in high- grade squamous intraepithelial lesions and cancer // Journal of gynecologic oncology. – 2016. – Vol. 2. – P. 24-27.; Tang Y., Su Y., Xu Y., Zhang Y., Shen Y., Qin L., Zhang L., Cao L., Zhou Y., Zhang T. Therapeutic effects of topical photodynamic therapy with 5-aminolevulinic acid on cervical high-grade squamous intraepithelial lesions // Photodiagnosis and Photodynamic Therapy. – 2022. – Vol. 39. – P. 102884.; Zhang W., Zhang A., Sun W., Yue Y., Li H. Efficacy and safety of photodynamic therapy for cervical intraepithelial neoplasia and human papilloma virus infection: A systematic review and meta- analysis of randomized clinical trials // Medicine. – 2018. – Vol. 21. – P. e10864.; Wang X., You L., Zhang W., Ma Y., Tang Y., Xu W. Evaluation of 5-aminolevulinic acid-mediated photodynamic therapy on cervical low-grade squamous intraepithelial lesions with high-risk HPV infection // Photodiagnosis and Photodynamic Therapy. – 2022. – Vol. 38. – P. 102807.; Ran R., Wang M., Li X., Liu Q. A prospective study of photodynamic therapy for cervical squamous intraepithelial lesion // Photodiagnosis and Photodynamic therapy. – 2021. – Vol. 34. – P. 102185.; Kim Y.-T., Lee J. M., Hur S.-Y., Cho C.-H., Kim Y. T., Kim S. C., Kang S. B. Clearance of human papillomavirus infection after successful conization in patients with cervical intraepithelial neoplasia // International Journal of Cancer. – 2010. – Vol. 8. – P. 1903-1909.; Kim H. S., Kwon J. E., Kim J. H., Kim A., Lee N. R., Kim M., Lee M., Suh D. H., Kim Y. B. Efficacy of loop electrosurgical excision procedure with cold coagulation for treating cervical intraepithelial neoplasia: A two center cohort study // Obstet Gynecol Sci. – 2017. – Vol. 2. – P. 200-206.; Qu Z., Wang Z., Qiu S., Cui G., Li C. Efficacy of photodynamic therapy with 5-aminolevulinic acid for the treatment of cervical high-grade squamous intraepithelial lesions with high-risk HPV infection: A retrospective study // Photodiagnosis and Photodynamic Therapy. – 2022. – Vol. 40. – P. 103068.; Pretorius R. G., Belinson J. L., Peterson P., Azizi F., Lo A. Yield and mode of diagnosis of cervical intraepithelial neoplasia 3 or cancer among women with negative cervical cytology and positive high- risk human papillomavirus test results // Journal of lower genital tract disease. – 2013. – Vol. 4. – P. 430-439.; Zhang W., Zhang A., Sun W., Yue Y., Li H. Efficacy and safety of photodynamic therapy for cervical intraepithelial neoplasia and human papilloma virus infection: A systematic review and meta- analysis of randomized clinical trials // Medicine. – 2018. – Vol. 21. – P. 47-54.; Maździarz A. Successful pregnancy and delivery following selective use of photodynamic therapy in treatment of cervix and vulvar diseases // Photodiagnosis and photodynamic therapy. – 2019. – Vol. 28. – P. 65-68.; Hillemanns P., Garcia F., Petry K. U., Dvorak V., Sadovsky O., Iversen O.-E., Einstein M. H. A randomized study of hexaminolevulinate photodynamic therapy in patients with cervical intraepithelial neoplasia 1/2 // American journal of obstetrics and gynecology. – 2015. – Vol. 4. – P. 465. e1-465. e7.; Waitzman N. J., Jalali A., Grosse S. D. Preterm birth lifetime costs in the United States in 2016: An update // seminars in Perinatology. – 2021. – Vol. 45. – P. 151390.

  5. 5
  6. 6
    Academic Journal

    Contributors: 1

    Source: Almanac of Clinical Medicine; Vol 53, No 2 (2025); 83-94 ; Альманах клинической медицины; Vol 53, No 2 (2025); 83-94 ; 2587-9294 ; 2072-0505

    File Description: application/pdf

  7. 7
    Academic Journal

    Source: Meditsinskiy sovet = Medical Council; № 4 (2025); 26-34 ; Медицинский Совет; № 4 (2025); 26-34 ; 2658-5790 ; 2079-701X

    File Description: application/pdf

    Relation: https://www.med-sovet.pro/jour/article/view/9021/7838; Audirac-Chalifour A, Torres-Poveda K, Bahena-Roman M, Tellez-Sosa J, Martinez-Barnetche J et al. Cervical microbiome and cytokine profile at various stages of cervical cancer: a pilot study. PloS ONE. 2016;11(4):e0153274. https://doi.org/10.1371/journal.pone.0153274.; Castle PE, Hillier SL, Rabe LK, Hildesheim A, Herrero R, Bratti MC et al. An association of cervical inflammation with highgrade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev. 2001;10(10):1021–1027. Available at: https://pubmed.ncbi.nlm.nih.gov/11588127/.; Castellsagué X. Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol. 2008;110(3 Suppl 2):S4–7. https://doi.org/10.1016/j.ygyno.2008.07.045.; Chase D, Goulder A, Zenhausern F, Monk B, Herbst-Kralovetz M. The vaginal and gastrointestinal microbiomes in gynecologic cancers: a review of applications in etiology, symptoms and treatment. Gynecol Oncol. 2015;138(1):190–200. https://doi.org/10.1016/j.ygyno.2015.04.036.; Komesu YM, Dinwiddie DL, Richter HE, Lukacz ES, Sung VW, Siddiqui NY et al. Defining the relationship between vaginal and urinary microbiomes. Am J Obstet Gynecol. 2020;222(2):154.e1–154.e10. https://doi.org/10.1016/j.ajog.2019.08.011.; Chen C, Song X, Wei W, Zhong H, Dai J, Lan Z et al. The microbiota continuum along the female reproductive tract and its relation to uterine-related diseases. Nat Commun. 2017;8(1):875. https://doi.org/10.1038/s41467-017-00901-0.; Brusselaers N, Shrestha S, van de Wijgert J, Verstraelen H. Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: systematic review and meta-analysis. Am J Obstet Gynecol. 2019;221(1):9–18. https://doi.org/10.1016/j.ajog.2018.12.011.; Greenbaum S, Greenbaum G, Moran-Gilad J, Weintraub AY. Ecological dynamics of the vaginal microbiome in relation to health and disease. Am J Obstet Gynecol. 2019;220(4):324–335. https://doi.org/10.1016/j.ajog.2018.11.1089.; Mitra A, MacIntyre DA, Ntritsos G, Smith A, Tsilidis KK, Marchesi JR et al. The vaginal microbiota associates with the regression of untreated cervical intraepithelial neoplasia 2 lesions. Nat Commun. 2020;11(1):1999. https://doi.org/10.1038/s41467-020-15856-y.; Amabebe E, Anumba DO. The Vaginal Microenvironment: The Physiologic Role of Lactobacilli. Front Med. 2018;5:181. https://doi.org/10.3389/fmed.2018.00181.; Mitra A, MacIntyre DA, Marchesi JR, Lee YS, Bennett PR, Kyrgiou M. The vaginal micro- biota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next? Microbiome. 2016;4(1):58. https://doi.org/10.1186/s40168-016-0203-0.; Zhou X, Brown CJ, Abdo Z, Davis CC, Hansmann MA, Joyce P et al. Differences in the composition of vaginal microbial communi- ties found in healthy Caucasian and black women. ISME J. 2007;1(2):121–133. https://doi.org/10.1038/ismej.2007.12.; Łaniewski P, Barnes D, Goulder A, Cui H, Roe DJ, Chase DM, Herbst-Kralovetz MM. Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women. Sci Rep. 2018;8(1):7593. https://doi.org/10.1038/s41598-018-25879-7.; Green KA, Zarek SM, Catherino WH. Gynecologic health and disease in relation to the microbiome of the female reproductive tract. Fertil Steril. 2015;104(6):1351–1357. https://doi.org/10.1016/j.fertnstert.2015.10.010.; Chico RM, Mayaud P, Ariti C, Mabey D, Ronsmans C, Chandramohan D. Prevalence of malaria and sexually transmitted and re- productive tract infections in pregnancy in sub-Saharan Africa: a systematic review. JAMA. 2012;307(19):2079–2086. https://doi.org/10.1001/jama.2012.3428.; Gosmann C, Anahtar MN, Handley SA, Farcasanu M, Abu-Ali G, Bowman BA et al. Lactobacillus-Deficient Cervicovaginal Bacterial Communities Are Associated with Increased HIV Acquisition in Young South African Women. Immunity. 2017;46(1):29–37. https://doi.org/10.1016/j.immuni.2016.12.013.; Koumans EH, Sternberg M, Bruce C, McQuillan G, Kendrick J, Sutton M et al. The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symp- toms, sexual behaviors, and reproductive health. Sex Transm Dis. 2007;34(11):864–869. https://doi.org/10.1097/olq.0b013e318074e565.; Spear GT, French AL, Gilbert D, Zariffard MR, Mirmonsef P, Sullivan TH et al. Human α-amylase present in lower-genital-tract mu- cosal fluid processes glycogen to support vaginal colonization by Lactobacillus. J Infect Dis. 2014;210(7):1019–1028. https://doi.org/10.1093/infdis/jiu231.; Vodstrcil LA, Hocking JS, Law M, Walker S, Tabrizi SN, Fairley CK, Bradshaw CS. Hormonal con- traception is associated with a reduced risk of bacterial vaginosis: a systematic review and meta-analysis. PLoS ONE. 2013;8(9):e73055. https://doi.org/10.1371/journal.pone.0073055.; Jespers V, van de Wijgert J, Cools P, Verhelst R, Verstraelen H, Delany-Moretlwe S et al. The signif-icance of Lactobacillus crispatus and L. vagi- nalis for vaginal health and the negative effect of recent sex: a cross-sectional descriptive study across groups of African women. BMC Infect Dis. 2015;15(1):115. https://doi.org/10.1186/s12879-015-0825-z.; Prokopczyk B, Cox JE, Hoffmann D, Waggoner SE. Identification of tobaccospecific carcinogen in the cervical mucus of smokers and nonsmokers. J Natl Cancer Inst. 1997;89(12):868–873. https://doi.org/10.1093/jnci/89.12.868.; Wei L, Griego AM, Chu M, Ozbun MA. Tobacco exposure results in increased E6 and E7 oncogene expression, DNA damage and mu- tation rates in cells maintaining episomal hu- man papillomavirus 16 genomes. Carcinogenesis. 2014;35(10):2373–2381. https://doi.org/10.1093/carcin/bgu156.; Hill GB. The microbiology of bacterial vaginosis. Am J Obstet Gynecol. 1993;169(2 Pt 2):450–454. https://doi.org/10.1016/0002-9378(93)90339-k.; Winters AD, Romero R, Gervasi MT, Gomez-Lopez N, Tran MR, Garcia-Flores V et al. Does the endometrial cavity have a molecu lar microbial signature? Sci Rep. 2019;9(1):9905. https://doi.org/10.1038/s41598-019-46173-0.; Chen Y, Qiu X, Wang W, Li D, Wu A, Hong Z et al. Human papillomavirus infection and cervical intraepithelial neoplasia progression are associated with increased vaginal microbiome diversity in a Chinese cohort. BMC Infect Dis. 2020;20(1):629. https://doi.org/10.1186/s12879-020-05324-9.; So KA, Yang EJ, Kim NR, Hong SR, Lee JH, Hwang CS et al. Changes of vaginal microbiota during cervical carcinogenesis in women with human papillomavirus infection. PLoS ONE. 2020;15(9):e0238705. https://doi.org/10.1371/journal.pone.0238705.; Łaniewski P, Cui H, Roe DJ, Barnes D, Goulder A, Monk BJ et al. Features of the cervicovaginal microenvironment drive cancer biomarker signatures in patients across cervical carcinogenesis. Sci Rep. 2019;9(1):7333. https://doi.org/10.1038/s41598-019-43849-5.; Wiik J, Sengpiel V, Kyrgiou M, Nilsson S, Mitra A, Tanbo T et al. Cervical microbiota in women with cervical intra-epithelial neoplasia, prior to and after local excisional treatment, a Norwegian cohort study. BMC Womens Health. 2019;19(1):30. https://doi.org/10.1186/s12905-019-0727-0.; Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SSK, McCulle SL et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci USA. 2011;108(1):4680–4687. https://doi.org/10.1073/pnas.1002611107.; Fettweis JM, Brooks JP, Serrano MG, Sheth NU, Girerd PH, Edwards DJ et al. Differences in vaginal microbiome in African American women versus women of European ancestry. Microbiology. 2014;160:2272–2282. https://doi.org/10.1099/mic.0.081034-0.; Van de Wijgert JHHM, Jespers V. The global health impact of vaginal dysbiosis. Res Microbiol. 2017;168(9-10):859–864. https://doi.org/10.1016/j.resmic.2017.02.003.; White BA, Creedon DJ, Nelson KE, Wilson BA. The vaginal microbiome in health and disease. Trends Endocrinol Metab. 2011;22(10):389–393. https://doi.org/10.1016/j.tem.2011.06.001.; Tachedjian G, Aldunate M, Bradshaw CS, Cone RA. The role of lactic acid production by probiotic Lactobacillus species in vaginal health. Res Microbiol. 2017;168(9-10):782–792. https://doi.org/10.1016/j.resmic.2017.04.001.; Petrova MI, Reid G, Vaneechoutte M, Lebeer S. Lactobacillus iners: friend or Foe? Trends Microbiol. 2017;25(3):182–191. https://doi.org/10.1016/j.tim.2016.11.007.; Moscicki AB, Shi B, Huang H, Barnard E, Li H. Cervical-vaginal microbiome and associated cytokine profiles in a prospective study of HPV 16 acquisition, persistence, and clearance. Front Cell Infect Microbiol. 2020;10:569022. https://doi.org/10.3389/fcimb.2020.569022.; Ilhan ZE, Łaniewski P, Thomas N, Roe DJ, Chase DM, Herbst-Kralovetz MM. Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling. EBioMedicine. 2019;44:675–690. https://doi.org/10.1016/j.ebiom.2019.04.028.; Mitra A, MacIntyre DA, Lee YS, Smith A, Marchesi JR, Lehne B et al. Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity. Sci Rep. 2015;516865. https://doi.org/10.1038/srep16865.; Kwasniewski W, Wolun-Cholewa M, Kotarski J, Warchol W, Kuzma D, Kwasniewska A, Gozdzicka-Jozefiak A. Microbiota dysbiosis is associated with HPV-induced cervical carcinogenesis. Oncol Lett. 2018;16(6):7035–7047. https://doi.org/10.3892/ol.2018.9509.; Di Paola M, Sani C, Clemente AM, Iossa A, Perissi E, Castronovo G et al. Characterization of cervico-vaginal microbiota in women developing persistent high-risk Human Papillomavirus infection. Sci Rep. 2017;7(1):10200. https://doi.org/10.1038/s41598-017-09842-6.; Palma E, Recine N, Domenici L, Giorgini M, Pierangeli A, Panici PB. Long-term Lactobacillus rhamnosus BMX 54 application to restore a balanced vaginal ecosystem: a prom- ising solution against HPV-infection. BMC Infect Dis. 2018;18(1):13. https://doi.org/10.1186/s12879-017-2938-z.; Brusselaers N, Shrestha S, van de Wijgert J, Verstraelen H. Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: systematic review and meta-analysis. Am J Obstet Gynecol. 2019;221(1):9–18.e8. https://doi.org/10.1016/j.ajog.2018.12.011.; Walther-Antonio MRS, Chen J, Multinu F, Hokenstad A, Distad TJ, Cheek EH et al. Potential contribution of the uterine microbiome in the development of endometrial cancer. Genome Med. 2016;8(1):122. https://doi.org/10.1186/s13073-016-0368-y.; Baker JM, Chase DM, Herbst-Kralovetz MM. Uterine microbiota: residents, tourists, or invaders? Front Immunol. 2018;9:208. https://doi.org/10.3389/fimmu.2018.00208.; Baker JM, Al-Nakkash L, Herbst-Kralovetz MM. Estrogen-gut microbiome axis: physiological and clinical implications. Maturitas. 2017;103:45–53. https://doi.org/10.1016/j.maturitas.2017.06.025.; Cheng H, Wang Z, Cui L, Wen Y, Chen X, Gong F et al. Opportunities and challenges of the human microbiome in ovarian cancer. Front Oncol. 2020;10:163. https://doi.org/10.3389/fonc.2020.00163.; Flores R, Shi J, Fuhrman B, Xu X, Veenstra TD, Gail MH et al. Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study. J Transl Med. 2012;10:253. https://doi.org/10.1186/1479-5876-10-253.; Cicinelli E, De Ziegler D, Nicoletti R, Colafiglio G, Saliani N, Resta L et al. Chronic endometritis: correlation among hystero- scopic, histologic, and bacteriologic findings in a prospective trial with 2190 consecutive office hysteroscopies. Fertil Steril. 2008;89(3):677–684. https://doi.org/10.1016/j.fertnstert.2007.03.074.; Dossus L, Rinaldi S, Becker S, Lukanova A, Tjonneland A, Olsen A et al. Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study. Endocr Relat Cancer. 2010;17(4):1007–1019. https://doi.org/10.1677/erc-10-0053.; Doerflinger SY, Throop AL, Herbst-Kralovetz MM. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner. J Infect Dis. 2014;209(12):1989–1999. https://doi.org/10.1093/infdis/jiu004.; Walsh DM, Hokenstad AN, Chen J, Sung J, Jenkins GD, Chia N et al. Postmenopause as a key factor in the composition of the Endometrial Cancer Microbiome (ECbiome). Sci Rep. 2019;9(1):19213. https://doi.org/10.1038/s41598-019-55720-8.; Shanmughapriya S, Senthilkumar G, Vinodhini K, Das BC, Vasanthi N, Natarajaseenivasan K. Viral and bacterial aetiologies of epithelial ovarian cancer. Eur J Clin Microbiol Infect Dis. 2012;31(9):2311–2317. https://doi.org/10.1007/s10096-012-1570-5.; Idahl A, Le Cornet C, González Maldonado S, Waterboer T, Bender N, Tjønneland A et al. Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk: results from the EPIC cohort. Int J Cancer. 2020;147(8):2042–2052. https://doi.org/10.1002/ijc.32999.; Fortner RT, Terry KL, Bender N, Brenner N, Hufnagel K, Butt J et al. Sexually transmitted infections and risk of epithelial ovarian cancer: results from the Nurses’ Health Studies. Br J Cancer. 2019;120(8):855–860. https://doi.org/10.1038/s41416-019-0422-9.; Banerjee S, Tian T, Wei Z, Shih N, Feldman MD, Alwine JC et al. The ovarian cancer oncobiome. Oncotarget. 2017;8(22):36225–36245. https://doi.org/10.18632/oncotarget.16717.; Zhou B, Sun C, Huang J, Xia M, Guo E, Li N et al. The biodiversity composition of microbiome in ovarian carcinoma patients. Sci Rep. 2019;9(1):1691. https://doi.org/10.1038/s41598-018-38031-2.; Miao R, Badger TC, Groesch K, Diaz-Sylvester PL, Wilson T, Ghareeb A et al. Assessment of peritoneal microbial features and tumor marker levels as potential diagnostic tools for ovarian cancer. PLoS ONE. 2020;15(1):е0227707. https://doi.org/10.1371/journal.pone.0227707.; Xu S, Liu Z, Lv M, Chen Y, Liu Y. Intestinal dysbiosis promotes epithelialmesenchymal transition by activating tumor-associated macrophages in ovarian cancer. Pathog Dis. 2019;77(2):ftz019. https://doi.org/10.1093/femspd/ftz019.; Ebner S, Smug LN, Kneifel W, Salminen SJ, Sanders ME. Probiotics in dietary guidelines and clinical recommendations outside the European Union. World J Gastroenterol. 2014;20(43):16095–16100. https://doi.org/10.3748/wjg.v20.i43.16095.; Li Y, Yu T, Yan H, Li D, Yu T, Yuan T et al. Vaginal Microbiota and HPV Infection: Novel Mechanistic Insights and Therapeutic Strategies. Infect Drug Resist. 2020;13:1213–20. https://doi.org/10.2147/idr.s210615.; Reid G. Has knowledge of the vaginal micro- biome altered approaches to health and dis- ease? F1000 Res. 2018;7(0):460. https://doi.org/10.12688/f1000research.13706.1.; Verhoeven V, Renard N, Makar A, Van Royen P, Bogers JP, Lardon F et al. Probiotics enhance the clearance of human papilloma- virus-related cervical lesions: a prospective controlled pilot study. Eur J Cancer Prev. 2013;22(1):46–51. https://doi.org/10.1097/cej.0b013e328355ed23.; Савичева АМ, Шалепо КВ, Назарова ВВ, Менухова ЮН. Сравнительное контролируемое рандомизированное исследование оценки эффективности двухэтапного лечения бактериального вагиноза. Гинекология. 2013;15(5):12–15. Режим доступа: https://mamababy-spb.ru/articles/lactabest/.

  8. 8
    Academic Journal

    Contributors: The authors express their sincere gratitude to the staff of the St. Petersburg Population Cancer Registry for their assistance in conducting the study., Авторы выражают искреннюю благодарность сотрудникам Популяционного ракового регистра Санкт-Петербурга за помощь в проведении исследования.

    Source: Epidemiology and Vaccinal Prevention; Том 23, № 6 (2024); 24-33 ; Эпидемиология и Вакцинопрофилактика; Том 23, № 6 (2024); 24-33 ; 2619-0494 ; 2073-3046

    File Description: application/pdf

    Relation: https://www.epidemvac.ru/jour/article/view/2116/1079; Wild C.P., Weiderpass E., Stewart B.W. World Cancer Report: Cancer Research for Cancer Prevention. Lyon, France: International Agency for Research on Cancer. 2020. Доступно на: http://publications.iarc.fr/586. Ссылка активна на 3 февраля 2024.; Cancer Research UK. In situ cervical carcinoma incidence statistics. 2020. Доступно на: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statisticsby-cancer-type/cervical-cancer/incidence-in-situ#heading-Zero. Ссылка активна на 4 апреля 2024.; Гарелик Т. М., Наумов И. А. Изучение клинико-эпидемиологической ситуации по выявлению рака шейки матки в гродненской области как элемент разработки мер вторичной профилактики // Современные проблемы гигиены, радиационной и экологической медицины. 2017. № 7. С. 33–44.; Каприн А. Д., Старинский В. В., Шахзадова А. О. и др. Злокачественные новообразования в России в 2022 году (заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России; 2023.; Хоров О. Г., Никита Е. И., Плавский Д. М. Евразийский. Дифференциальная диагностика облигатных заболеваний гортани. Евразийский онкологический журнал. 2019. Т. 7, № 3. С. 304–312.; Степанова Ю. Е., Готовяхина Т. В., Корень Е. Е. и др. Эндоскопическая диагностика предопухолевых заболеваний и рака гортани в практике врача-фониатра // Российская оториноларингология. 2017. № 6 (91). С. 128–134.; Markou K., Christoforidou A., Karasmanis I., et al. Laryngeal cancer: epidemiological data from Νorthern Greece and review of the literature // Hippokratia. 2013; Vol. 17, №4. Р. 313–318.; Nelson R.A., Levine A.M., Bernstein L., et al. Changing patterns of anal canal carcinoma in the United States // J Clin Oncol. 2013. Vol. 31, №12. Р. 1569–1575. doi:10.1200/JCO.2012.45.2524.; Ho V.K.Y., Deijen C.L., Hemmes B., et al. Trends in epidemiology and primary treatment of anal squamous cell carcinoma in the Netherlands (1990-2021) // Int J Cancer. 2024. Vol. 154, №9. Р. 1569–1578. doi:10.1002/ijc.34811.; Bucchi L., Pizzato M., Rosso S., et al. New Insights into the Epidemiology of Vulvar Cancer: Systematic Literature Review for an Update of Incidence and Risk Factors // Cancers (Basel). 2022. Vol. 14, № 2. Р. 389. doi:10.3390/cancers14020389.; Oonk M.H.M., Planchamp F., Baldwin P., et al. European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023 // Int J Gynecol Cancer. 2023. Vol. 33, №7. Р. 1023–1043. doi:10.1136/ijgc-2023-004486.; Judson P.L., Habermann E.B., Baxter N.N., et al. Trends in the incidence of invasive and in situ vulvar carcinoma // Obstetrics and Gynecology. 2006. Vol. 107, №5. Р. 1018–1022. doi:10.1097/01.AOG.0000210268.57527.a1.; Gadducci A., Fabrini M.G., Lanfredini N., et al. Squamous Cell Carcinoma of the Vagina: Natural History, Treatment Modalities and Prognostic Factors // Crit Rev Oncol Hematol. 2015. Vol. 93. Р. 211–224. doi:10.1016/j.critrevonc.2014.09.002.; IARC, Urinary and Male Genital Tumours. WHO Classification of Tumours, 5th Edn. Vol. 8. 2022. Доступно по: https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/Urinary-And-Male-Genital-Tumours-2022. Ссылка активна на 18 апреля 2024.; Муравьева Е. С., Богданова Н. А. Опыт диагностики и лечения эритроплазии Кейра // Тверской медицинский журнал. 2023. № 6. С. 25–28.; Giona S., Barber N., Ali A., editors. The Epidemiology of Penile Cancer // Urologic Cancers [Internet]. Brisbane (AU): Exon Publications. 2022. Chapter 11. doi:10.36255/exonpublications- urologic-cancers-epidemiology-penile-cancer.; Лялина Л.В., Холопов Д.В., Хижа В.В., и др. Гендерные особенности злокачественных новообразований, ассоциированных с вирусом папилломы человека, в Санкт-Петербурге // Пермский медицинский журнал. 2022. Т. 39, №4. С. 144–154.; Лялина Л.В., Холопов Д.В., Язенок А.В., и др. Клинико-эпидемиологическая характеристика злокачественных новообразований, ассоциированных с вирусом папилломы человека, в регионах Северо-Запада России // Журнал микробиологии, эпидемиологии и иммунобиологии. 2023. Т. 100, №1. С. 52–64.; Макарова Е.В., Сеньчукова М.А. Рак шейки матки в Оренбургской области и Российской Федерации за 2007-2016 годы // Оренбургский медицинский вестник. 2018. Т. 6, №4(24). С. 20–30.; EAU Guidelines // Edn. presented at the EAU Annual Congress Paris. 2024. Доступно по: https://uroweb.org/guidelines/penile-cancer/chapter/citation-information. Ссылка активна на 2 мая 2024.; Siegel R.L., Giaquinto A.N., Jemal A. Cancer statistics, 2024 // CA Cancer J Clin. 2024. Vol. 74, №1. Р. 12‐49. doi:10.3322/caac.21820.; Mix J.M., Van Dyne E.A., Saraiya M., et al. Assessing Impact of HPV Vaccination on Cervical Cancer Incidence among Women Aged 15-29 Years in the United States, 1999-2017: An Ecologic Study // Cancer Epidemiol Biomarkers Prev. 2021. Vol. 30, №1. Р. 30–37. doi:10.1158/1055-9965.EPI-20-0846.; Baandrup L., Maltesen T., Dehlendorff C., et al. Human papillomavirus vaccination and anal high-grade precancerous lesions and cancer—a real-world effectiveness study // JNCI: Journal of the National Cancer Institute. 2024. Vol. 116, №2. P. 283–287. doi:10.1093/jnci/djad189.; Elst L., Albersen M. HPV Vaccination: Does It Have a Role in Preventing Penile Cancer and Other Preneoplastic Lesions? // Semin Oncol Nurs. 2022. Vol. 38, №3. Р. 151284. doi:10.1016/j.soncn.2022.151284.; https://www.epidemvac.ru/jour/article/view/2116

  9. 9
    Academic Journal

    Source: CHILDREN INFECTIONS; Том 24, № 1 (2025); 37-42 ; ДЕТСКИЕ ИНФЕКЦИИ; Том 24, № 1 (2025); 37-42 ; 2618-8139 ; 2072-8107

    File Description: application/pdf

    Relation: https://detinf.elpub.ru/jour/article/view/1031/704; Derkay CS, Bluher AE: Update on recurrent respiratory papillomatosis. Otolaryngol Clin North Am. 2019; 52(4):669—679. doi:10.1016/j.otc.2019.03.011; Steben M., Duarte-Franco E. Human papillomavirus infection: Epidemiology and pathophysiology. Gynecol Oncol. 2007; 107:S2—S5. doi:10.1016/j.ygyno.2007.07.067.; Serrano B., Brotons M., Bosch F.X., Bruni L. Epidemiology and burden of HPV-related disease. Best Pract. Res. Clin. Obstet. Gynaecol. 2018; 47: 14—26. doi:10.1016/j.bpobgyn.2017.08.006.; Кинзикеева Э. Р., Болис Д., Ливерани К. А. Папилломавирусная инфекция. История открытия, эпидемиология, факторы риска. Медицинский вестник Башкортостана. 2009.; Forman D., de Martel C., Lacey C.J., Soerjomataram I., Lortet-Tieulent J., Bruni L., Vignat J., Ferlay J., Bray F., Plummer M., et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012; 30 (Suppl.5):F12—F23. doi:10.1016/j.vaccine.2012.07.055.; De Martel C., Plummer M., Vignat J., Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int. J. Cancer. 2017; 141:664—670. doi:10.1002/ijc.30716.; Стукань А.И., Чухрай О.Ю., Порханов В.А., Мурашко Р.А., Бодня В.H., Макарова Ю.М. Орофарингеальная карцинома, ассоциированная с вирусом папилломы человека: тенденции эпидемиологии и методы выявления вируса в опухоли. Опухоли головы и шеи. 2018; 8(3):77—83.); La Rosa G. Papillomavirus. In: Global Water Pathogen Project. Rose JB and Jimйnez-Cisneros B (eds) (Meschke J.S. and Girones R. (eds) Part 3 Viruses). Michigan State University, E. Lansing, MI, Unesco, 2016.; Караченцова И.В., Сибирская Е.В., Фомина М.М., Дядик Т.Г. Состояние репродуктивной системы девочек-подростков после вакцинации против вируса папилломы человека с использованием четырехвалентной вакцины. Педиатрическая фармакология. 2024; 21(2): 111— 118. https://doi.org/10.15690/pf.v21i2.2716; Fabbrocini G., S. Cacciapuoti and G. Monfrecola. Human Papillomavirus Infection in Child. The Open Dermatology Journal. 2009; 3:111—16.; Kombe Kombe AJ, Li B, Zahid A, Mengist HM, Bounda G-A, Zhou Y and Jin T. Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation. Front. Public Health. 2020; 8:552028. doi:10.3389/fpubh.2020.552028; Ardekani A., Taherifard E., Mollalo A., Hemadi E., Roshanshad A., Fereidooni R., Rouholamin S., Rezaeinejad M., Farid-Mojtahedi M., Razavi M., and Rostami A. Human Papillomavirus Infection during Pregnancy and Childhood: A Comprehensive Review. Microorganisms. 2022 Oct; 10(10):1932. Published online 2022 Sep 28. doi:10.3390/microorganisms10101932.; Ardekani A., Sepidarkish M., Mollalo A., Afradiasbagharani P., Rouholamin S., Rezaeinejad M., Farid-Mojtahedi M., Mahjour S., Almukhtar M., Nourollahpour Shiadeh M., et al. Worldwide prevalence of human papillomavirus among pregnant women: A systematic review and meta-analysis. Rev. Med. Virol. 2022:e2374. doi:10.1002/rmv.2374.; Rombaldi R.L., Serafini E.P., Mandelli J., Zimmermann E., Losquiavo K.P. Transplacental transmission of Human Papillomavirus. Virol. J. 2008; 5:106. doi:10.1186/1743-422X-5-106.; Trottier H., Mayrand M.H., Coutlйe F., Monnier P., Laporte L., Niyibizi J., Carceller A.M., Fraser W.D., Brassard P., Lacroix J., et al. Human papillomavirus (HPV) perinatal transmission and risk of HPV persistence among children: Design, methods and preliminary results of the HERITAGE study. Papillomavirus Res. 2016; 2:145—152. doi:10.1016/j.pvr.2016.07.001.; Zouridis A., Kalampokas T., Panoulis K., Salakos N., Deligeoroglou E. Intrauterine HPV transmission: A systematic review of the literature. Arch. Gynecol. Obstet. 2018; 298:35—44. doi:10.1007/s00404-018-4787-4.; Wang X., Zhu Q., Rao H. Maternal-fetal transmission of human papillomavirus. Chin. Med. J. 1998; 111:726—727.; Краснопольский В.И., Зароченцева Н.В., Микаелян А.В., Кещьян Л.В., Лазарева И.Н. Роль папилломавирусной инфекции в патологии беременности и исходе для новорожденного (современные представления). Российский вестник акушера-гинеколога. 2016; 16(2):30—36.; Zgura A.F., Bratila E., Vladareanu S. Transplacental Transmission of Human Papillomavirus. Maedica. 2015; 10:159—162.; Chatzistamatiou K., Sotiriadis A., Agorastos T. Effect of mode of delivery on vertical human papillomavirus transmission—A meta-analysis. J. Obstet. Gynaecol. 2016; 36:10—14. doi:10.3109/01443615.2015.1030606.; Koskimaa H.M., Waterboer T., Pawlita M., Grйnman S., Syrjдnen K., Syrjдnen S. Human papillomavirus genotypes present in the oral mucosa of newborns and their concordance with maternal cervical human papillomavirus genotypes. J. Pediatr. 2012; 160:837—843. doi:10.1016/j.jpeds.2011.10.027.; Castellsague X., Drudis T., Caсadas M.P., Goncй A., Ros R., Pйrez J.M., Quintana M.J., Muсoz J., Albero G., de Sanjosй S., et al. Human Papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: A prospective study in Spain. BMC Infect. Dis. 2009; 9:74. doi:10.1186/1471-2334-9-74.; Workowski K.A., Bolan G.A. Sexually transmitted diseases treatment guidelines. MMWR Recomm. Rep. 2015; 64:1—137.; Cunningham F.G., Leveno K.J., Bloom S.L., Dashe J.S., Hoffman B.L., Casey B.M., Spong C.Y. Williams Obstetrics. 25th ed. McGraw-Hill Education; New York, NY, USA: 2018. Neoplastic Disorders.; Silverberg MJ, Thorsen P, Lindeberg H, et al. Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis. Obstet Gynecol 2003; 101:645—52.; Society C.P. Skin care for your baby. Paediatr. Child. Health. 2007; 12:245—251. doi:10.1093/pch/12.3.245.; Petca A., Borislavschi A., Zvanca M.E., Petca R.C., Sandru F., Dumitrascu M.C. Non-sexual HPV transmission and role of vaccination for a better future (Review) Exp. Ther. Med. 2020; 20:186. doi:10.3892/etm.2020.9316.; Benjamin L.T., Levy M., Ofori A. Condylomata Acuminata (Anogenital Warts) in Children. UpToDate; Waltham, MA, USA: 2014.; Casalegno JS, Le Bail Carval K, Eibach D, Valdeyron ML, Lamblin G, Jacquemoud H, Mellier G, Lina B, Gaucherand P, Mathevet P, et al. High risk HPV contamination of endocavity vaginal ultrasound probes: An underestimated route of nosocomial infection? PLoS One. 2012; 7(e48137) doi:10.1371/journal.pone.0048137.; Gallay C, Miranda E, Schaefer S, Catarino R, Jacot-Guillarmod M, Menoud PA, Guerry F, Achtari C, Sahli R, Vassilakos P, et al. Human papillomavirus (HPV) contamination of gynaecological equipment. Sex Transm Infect. 2016; 92:19—23. doi:10.1136/sextrans-2014-051977.; Meyers J, Ryndock E, Conway MJ, et al. Susceptibility of high-risk human papillomavirus type 16 to clinical disinfectants. J Antimicrob Chemother. 2014; 69:1546—50.; Syrjanen S., Puranen M. Human Papillomavirus Infections in Children: The Potential Role of Maternal Transmission. Crit. Rev. Oral Biol. Med. 2000; 11:259—274. doi:10.1177/10454411000110020801.; Sonnex C., Strauss S., Gray J.J. Detection of human papillomavirus DNA on the fingers of patients with genital warts. Sex. Transm. Infect. 1999; 75: 317—319. doi:10.1136/sti.75.5.317.; Tay SK, Ho TH, Lim-Tan SK. Is genital human papillomavirus infection always sexually transmitted? Aust NZJ Obstet Gynaecol. 1990; 30:240— 242. doi:10.1111/j.1479-828x.1990.tb03223.x.; Mammas IN, Dalianis T, Doukas SG, Zaravinos A, Achtsidis V, Thiagarajan P, Theodoridou M, Spandidos DA. Paediatric virology and human papillomaviruses: An update. Exp Ther Med. 2019; 17:4337—4343. doi:10.3892/etm.2019.7516.; Campbell C.M.P., Kreimer A.R., Lin H.Y., Fulp W., O’Keefe M.T., Ingles D.J., Abrahamsen M., Villa L.L., Lazcano-Ponce E., Giuliano A.R. Long-term persistence of oral human papillomavirus type 16: The HPV Infection in Men (HIM) study. Cancer Prev. Res. 2015; 8:190—196. doi:10.1158/1940-6207.CAPR-14-0296.; Zhang L.-W., Wang W.-J., Li C.-H., Xu L., Liu X.-Y., Zheng L., Liu D.-X. A Case of Condyloma Acuminatum on the Nipple Detected via Dermoscopy. Int. J. Dermatol. Venereol. 2020; 3:125—126. doi:10.1097/01.JD9.0000563564.57133.50.; Saeki Y., Sato S., Okajima K., Ando N., Saeki H., Kawase M., Ito K., Nakagawa H., Ohtsuki M. Condyloma acuminatum of the nipple and areola. Int.J. Dermatol. 2014; 53:e171—e172. doi:10.1111/j.1365-4632.2012.05727.x.; Syrjänen S., Waterboer T., Rintala M., Pawlita M., Syrjänen K., Louvanto K., Grenman S. Maternal HPV-antibodies and seroconversion to HPV in children during the first 3 years of life. Sci. Rep. 2022; 12:2227. doi:10.1038/s41598-022-06343-z.; Cason J., Mant C.A. High-risk mucosal human papillomavirus infections during infancy & childhood. J. Clin. Virol. 2005; 32(Suppl. S1):S52—S58. doi:10.1016/j.jcv.2004.12.007.; https://detinf.elpub.ru/jour/article/view/1031

  10. 10
  11. 11
  12. 12
    Academic Journal

    Contributors: This research was funded by the Russian Scientific Foundation (grant No. 23-15-00433, https://rscf.ru/en/project/23-15-00433)., Исследование выполнено за счет гранта Российского научного фонда (грант № 23-15-00433, https://rscf.ru/project/23-15-00433).

    Source: Advances in Molecular Oncology; Vol 11, No 3 (2024); 56-67 ; Успехи молекулярной онкологии; Vol 11, No 3 (2024); 56-67 ; 2413-3787 ; 2313-805X

    File Description: application/pdf

  13. 13
  14. 14
    Academic Journal

    Source: Сборник статей

    File Description: application/pdf

    Relation: Актуальные вопросы современной медицинской науки и здравоохранения : Сборник статей IX Международной научно-практической конференции молодых ученых и студентов, 17-18 апреля 2024 г. Т. 1.; http://elib.usma.ru/handle/usma/21108

  15. 15
  16. 16
    Academic Journal

    Source: Сборник статей

    File Description: application/pdf

    Relation: Актуальные вопросы современной медицинской науки и здравоохранения : Сборник статей IX Международной научно-практической конференции молодых ученых и студентов, 17-18 апреля 2024 г. Т. 1.; http://elib.usma.ru/handle/usma/21308

  17. 17
    Academic Journal

    Contributors: Not specified., Отсутствует.

    Source: Pediatric pharmacology; Том 21, № 2 (2024); 111-118 ; Педиатрическая фармакология; Том 21, № 2 (2024); 111-118 ; 2500-3089 ; 1727-5776

    File Description: application/pdf

    Relation: https://www.pedpharma.ru/jour/article/view/2437/1581; Ferlay J, Ervik M, Lam F, et al. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021;149(4):778–789. doi: https://doi.org/10.1002/ijc.33588; Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: https://doi.org/10.3322/caac.21660; Злокачественные новообразования в России в 2021 году (заболеваемость и смертность) / под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. — М.: МНИОИ им. П.А. Герцена — филиал ФГБУ «НМИЦ радиологии» Минздрава России; 2022. — 252 с.; De Martel C, Georges D, Bray F, et al. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020;8(2):e180–e190. doi: https://doi.org/10.1016/s2214-109x(19)30488-7; Lei J, Ploner A, Elfström KM, et al. HPV Vaccination and the Risk of Invasive Cervical Cancer. N Engl J Med. 2020;383(14):1340– 1348. doi: https://doi.org/10.1056/NEJMoa1917338; Намазова-Баранова Л.С., Чемакина Д.С., Федосеенко М.В. и др. Обзор вакцинации против папилломавирусной инфекции в мире // Педиатрическая фармакология. — 2018. — Т. 15. — № 1. — С. 80–85. — doi: https://doi.org/10.15690/pf.v15i1.1846; Datta S, Pink J, Medley GF, et al. Assessing the cost-effectiveness of HPV vaccination strategies for adolescent girls and boys in the UK. BMC Infect Diseases. 2019;19(1):552. doi: https://doi.org/10.1186/s12879-019-4108-y; Привалова Т.Е., Суровцева О.В., Андриянов Д.В. Преимущества гендерно-нейтральной стратегии вакцинации для профилактики ВПЧ-ассоциированных заболеваний и искоренения ВПЧ-инфекции в целом. Актуальное состояние вакцинации против ВПЧ в мире // Педиатрическая фармакология. — 2021. — Т. 18. — № 3. — С. 239–244. — doi: https://doi.org/10.15690/pf.v18i3.2285; Newman L, Rowley J, Vander Hoorn S, et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on Systematic review and global reporting. PLoS One. 2015;10(12):e0143304. doi: https://doi.org/10.1371/journal.pone.0143304; McClymont E, Lee M, Raboud J, et al. The Efficacy of the Quadrivalent Human Papillomavirus Vaccine in Girls and Women Living With Human Immunodeficiency Virus. Clin Infect Dis. 2019;68(5):788. doi: https://doi.org/10.1093/cid/ciy575; Trimble CL, Morrow MP, Kraynyak KA, et al. Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial. Lancet. 2015;386(10008):2078– 2088. doi: https://doi.org/10.1016/s0140-6736(15)00239-1; Прилепская В.Н., Зардиашвили М.Д., Хлебкова Ю.С., Некрасова М.Е. Вакцинация против ВПЧ-ассоциированных заболеваний и рака шейки матки: теоретические и практические аспекты // Медицинский совет. — 2016. — № 12. — С. 120–125. — doi: https://doi.org/10.21518/2079-701x-2016-12-120-125; Вакцинопрофилактика заболеваний, вызванных вирусом папилломы человека: федеральные клинические рекомендации / Минздрав России; Союз педиатров России. — М.: ПедиатрЪ; 2017. — 48 с.; Вакцинопрофилактика заболеваний, вызванных вирусом папилломы человека: методические рекомендации для педиатров / Союз педиатров России; Независимый экспертный совет Союза экспертов в области иммунопрофилактики; Национальная ассоциация специалистов по контролю инфекций, связанных с оказанием медицинской помощи; Евро-Азиатское общество по инфекционным болезням. — М.: ПедиатрЪ; 2021. — 72 с.; Калюжная Т.А., Федосеенко М.В., Намазова-Баранова Л.С. и др. Преодоление антипрививочного скепсиса: поиски решения выхода из сложившейся ситуации // Педиатрическая фармакология. — 2018. — Т. 15. — № 2. — С. 141–148. — doi: https://doi.org/10.15690/pf.v15i2.1871; Lee KN, Chang KHJ, Cho SS, et al. Attitudes Regarding HPV Vaccinations of Children among Mothers with Adolescent Daughters in Korea. J Korean Med Sci. 2017;32(1):130–134. doi: https://doi.org/10.3346/jkms.2017.32.1.130; Методические рекомендации по выявлению, расследованию и профилактике побочных проявлений после иммунизации / Минздрав России. — М.; 2019. — 56 с.; Naleway AL, Mittendorf KF, Irving SA, et al. Primary Ovarian insufficiency and adolescent vaccination. Pediatrics. 2018;142(3):e20180943. doi: https://doi.org/10.1542/peds.2018-0943; Уварова Е.В. Гормональная контрацепция в подростковом периоде жизни // Репродуктивное здоровье детей и подростков. — 2018. — Т. 14. — № 2. — С. 78–96. — doi: https://doi.org/10.24411/1816-2134-2018-12009; ГАРДАСИЛ. Вакцина против вируса папилломы человека квадривалентная рекомбинантная (типов 6, 11, 16, 18) // Педиатрическая фармакология. — 2007. — Т. 4. — № 2. — С. 92–95.; Marques P, Madeira T, Gama A. Menstrual cycle among adolescents: girls’ awareness and influence of age at menarche and overweight. Rev Paul Pediatr. 2022;40:e2020494. doi: https://doi.org/10.1590/1984-0462/2022/40/2020494; Lei Y, Luo D, Yan X, et al. The mean age of menarche among Chinese schoolgirls declined by 6 months from 2005 to 2014. Acta Paediatr. 2021;110(2):549–555. doi: https://doi.org/10.1111/apa.15441; Ferries-Rowe E, Corey E, Archer JS. Primary Dysmenorrhea: Diagnosis and Therapy. Archer Obstet Gynecol. 2020;136(5):1047– 1058. doi: https://doi.org/10.1097/AOG.0000000000004096; McKenna KA, Fogleman CD. Dysmenorrhea. Am Fam Physician. 2021;104(2):164–170. 25. Patel S, Pushpalatha K, Singh B, Evaluation of Hormonal Profile and Ovarian Morphology among Adolescent Girls with Menstrual Irregularities in a Tertiary Care Centre at Central India. ScientificWorldJournal. 2022;2022:3047526. doi: https://doi.org/10.1155/2022/3047526; Witchel SF, Oberfield SE, Peña AS. Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls. J Endocr Soc. 2019;3(8):1545–1573. doi: https://doi.org/10.1210/js.2019-00078; Уварова Е.В. Аномальные маточные кровотечения пубертатного периода // Репродуктивное здоровье детей и подростков. — 2018. — № 1. — С. 64–91.; Гуменюк О.И., Черенков Ю.В. Заболевания молочных желез у девочек подросткового возраста // Репродуктивное здоровье детей и подростков. — 2020. — Т. 16. — № 4. — С. 96–101. — doi: https://doi.org/10.33029/1816-2134-2020-16-4-96-101; Адамян Л.В., Сибирская Е.В., Богданова Е.А. и др. Репродуктивное здоровье девочек и девушек г. Москвы. Предложения по сохранению репродуктивного потенциала // Репродуктивное здоровье детей и подростков. — 2016. — № 2. — С. 13–14.; Баранов А.А., Сухарева Л.М. Особенности состояния здоровья современных школьников // Вопросы современной педиатрии. — 2006. — Т. 5. — № 5. — С. 14–20.; https://www.pedpharma.ru/jour/article/view/2437

  18. 18
    Academic Journal

    Source: Biomedical Photonics; Том 13, № 3 (2024); 42-46 ; 2413-9432

    File Description: application/pdf

    Relation: https://www.pdt-journal.com/jour/article/view/661/472; https://www.pdt-journal.com/jour/article/view/661/497; Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Je mal A. Global cancer statistics 2020: GLOBOCAN estimates of in cidence and mortality worldwide for 36 cancers in 185 countries // CA Cancer J Clin. – 2021. – Vol.7.; Клинышкова Т.В. Стратегии цервикального скрининга: современный взгляд // Российский вестник акушера-гинеколога. – 2023. – Т.23, № 4. – С. 20-26.; Gosvig C.F., Huusom L.D., Andersen K.K., Duun-Henriksen A.K., Frederiksen K., Iftner A. et al. Long-term follow-up of the risk for cervical intraepithelial neoplasia grade 2 or worse in HPV-negative women after conization // Int J Cancer. – 2015. – Vol. 137(12). – Р. 2927-2933.; Белоцерковцева Л.Д., Давыдов А.И., Шахламова М.Н., Панкратов В.В. Современные концепции лечения пациенток с цервикальной интраэпителиальной неоплазией, ассоциированной с папилломавирусной инфекцией // Вопросы гинекологии, акушерства и перинатологии. – 2018. – Т.17, №4. – С. 120-124.; Зароченцева Н.В., Джиджихия Л.К., Набиева В.Н. Рецидивы цервикальных интраэпителиальных неоплазий после применения эксцизионных методов лечения // Вопросы гинекологии, акушерства и перинатологии. – 2020. – Т.19, №2. – С. 68-77.; Kalliala I., Athanasiou A., Veroniki A.A., Salanti G., Efthimiou O., Raftis N. et al. Incidence and mortality from cervical cancer and other malignancies after treatment of cervical intraepithelial neoplasia: a systematic review and meta-analysis of the literature // Ann Oncol. – 2020. – Vol. 31(2). – Р. 213-27.; Bruno M.T., Cassaro N., Garofalo S., Boemi S. HPV16 persistent infection and recurrent disease after LEEP // Virol J. – 2019. – Vol. 16(1). – Р. 148.; Chen L.M., Liu L., Tao X., He Y., Guo L.P., Zhang H.W. et al. Analysis of recurrence and its influencing factors in patients with cervical HSIL within 24 months after LEEP // Zhonghua Fu Chan Ke Za Zhi. – 2019. – Vol. 54(8). – Р. 534-40.; Кулаков В.И., Прилепская В.И., Минкина Г.Н., Роговская С.И. Профилактика рака шейки матки // Руководство для врачей – Кулаков В.И. – 2007. – С. 57.; Wu J., Jia Y., Luo M., Duan Z. Analysis of Residual/Recurrent Disease and Its Risk Factors after Loop Electrosurgical Excision Procedure for High-Grade Cervical Intraepithelial Neoplasia // Gynecol Obstet Invest. – 2016. – Vol. 81(4). – Р. 296-301.; Palmer J.E., Raveеnscrofрt S., Eсllis K., Crossяley J., Dudding N., Smith J.H. et al. Does Hoffman S.R., Le T., Lockhart A., Sanusi A., Dal Santo L., Davis M. et al. Patterns of persistent HPV infection after treatment for cervical intraepithelial neoplasia (CIN): A systematic review // Int J Cancer. – 2017. – Vol. 141(1). – Р. 8-23.; Kong T.W., Son J.H., Chang S.J., Paek J., Lee Y., Ryu H.S. Value of endocervical margin and high-risk human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia, adenocarcinoma in situ, and microinvasive carcinoma of the uterine cervix // Gynecol Oncol. – 2014. – Vol. 135(3). – Р. 468-73.; Zhang H., Zhang T., You Z., Zhang Y. Positive Surgical Margin, HPV Persistence and Expression of Both TPX2 and PD-L1 Are Associated with Persistence/Recurrence of Cervical Intraepithelial Neoplasia after Cervical Conization // PLoS One. – 2015. – Vol. 10(12).; Poomtavorn Y., Tanprasertkul C., Sammor A., Suwannarurk K., Thaweekul Y. Predictors of Absent High-grade Cervical Intraepithelial Neoplasia (CIN) in Loop Electrosurgical Excision Procedure Specimens of Patients with Colposcopic Directed Biopsy-Confirmed High-Grade CIN // Asian Pac J Cancer Prev. – 2019. – Vol. 20(3). – Р. 849-54.; Uijterwaal M.H., Kocken M., Berkhof J., Bekkers R.L., Verheijen R.H., Helmerhorst T.J., Meijer CJ. Posttreatment assessment of women at risk of developing high-grade cervical disease: proposal for new guidelines based on data from the Netherlands // J Low Genit Tract Dis. – 2014. – Vol. 18(4). – Р. 338-43.; Velentzis L.S., Brotherton J.M.L., Canfell K. Recurrent disease after treatment for cervical pre-cancer: determining whether prophylactic HPV vaccination could play a role in prevention of secondary lesions // Climacteric. – 2019. – Vol. 22(6). – Р. 596-602.; Santesso N., Mustafa R.A., Wiercioch W., Kehar R., Gandhi S., Chen Y., et al. Systematic reviews and meta-analyses of benefits and harms of cryotherapy, LEEP, and cold knife conization to treat cervical intraepithelial neoplasia // Int J.Gynaecol Obstet. – 2016. – Vol. 132(3). – Р. 266-71.; D’Alessandro P., Arduino B., Borgo M., Saccone G., Venturella R., Di Cello A. et al. Loop Electrosurgical Excision Procedure versus Cryotherapy in the Treatment of Cervical Intraepithelial NeoplasЭia: A Sлystemеatic Review and Meta-Analysis of Randomized Controlled Trials // Gynecol Minim Invкasive Ther. – 2018. – Vol. 7(4). Р. 45-51.; Fernández-Montolí M.E., Tous S., Medina G., Castellarnau M., García-Tejedor A., de Sanjosé S. Long-term predictors of residual or recurrent cervical intraepithelial neoplasia 2–3 after treatment with a large loop excision of the transformation zone: a retrospective study // BJOG. – 2020. – Vol. 127(3). – Р. 377-87.; «Флуоресцентная диагностика и фотодинамическая терапия в онкологии». Под редакцией В.И. Чиссова, Е.В. Филоненко. Москва. – 2012. – С. 160-173.

  19. 19
  20. 20